Department of Dermatology, Oulu University Hospital, University of Oulu and Medical Research Center, Oulu, Finland.
Br J Dermatol. 2014 Nov;171(5):1223-6. doi: 10.1111/bjd.13189. Epub 2014 Oct 19.
Bullous pemphigoid (BP) is an autoimmune blistering skin disease of elderly people. Some studies have suggested that the incidence of BP has increased, but the diagnostic accuracy and methodology of studies have varied considerably.
To examine the incidence of BP in Northern Finland, and whether the incidence has changed over time.
This was a retrospective database study of all BP cases diagnosed in the Oulu University Hospital, Finland between 1985 and 2009. The diagnostic criteria were clinical features characteristic of BP (all patients) and positive direct or indirect immunofluorescence in the skin biopsy. The age-standardized incidences were calculated by the direct standardization method. Incidence rate ratios (IRR) were estimated by the Poisson regression model. To derive adjusted IRRs, age and sex were used as potential confounding factors.
The crude incidence of BP was 17 per 1 million person-years [95% confidence interval (CI) 15-20] between 1985 and 2009. Using the general European population as a reference, the age-standardized incidence was 14 per 1 million person-years (95% CI 12-17). The incidence of BP increased 1·8-fold (IRR 1·8, 95% CI 1·3-2·6; P < 0·001) in 2005-09 compared with the mean incidence of BP between 1985 and 2004, but after the adjustment for age and sex the increase was 1·4-fold (IRR 1·4, 95% CI 1·0-2·0; P = 0·043).
This is the first study with immunohistologically verified BP diagnoses that reports the increase in the incidence of BP in age- and sex-adjusted populations.
大疱性类天疱疮(BP)是一种老年人自身免疫性水疱性皮肤病。一些研究表明,BP 的发病率有所增加,但研究的诊断准确性和方法差异很大。
检查芬兰北部 BP 的发病率,以及发病率是否随时间发生变化。
这是一项回顾性数据库研究,纳入了 1985 年至 2009 年间在芬兰奥卢大学医院诊断的所有 BP 病例。诊断标准为具有 BP 特征性的临床特征(所有患者)和皮肤活检的直接或间接免疫荧光阳性。采用直接标准化法计算年龄标准化发病率。采用泊松回归模型估计发病率比(IRR)。为了得出调整后的 IRR,年龄和性别被用作潜在的混杂因素。
1985 年至 2009 年间,BP 的粗发病率为 17 例/100 万人年[95%可信区间(CI)15-20]。以普通欧洲人群为参照,年龄标准化发病率为 14 例/100 万人年(95% CI 12-17)。与 1985 年至 2004 年期间 BP 的平均发病率相比,2005-09 年 BP 的发病率增加了 1.8 倍(IRR 1.8,95% CI 1.3-2.6;P<0.001),但在调整年龄和性别后,发病率增加了 1.4 倍(IRR 1.4,95% CI 1.0-2.0;P=0.043)。
这是第一项具有免疫组织化学验证的 BP 诊断的研究,报告了年龄和性别调整人群中 BP 发病率的增加。